Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Point Of Care Hematology Diagnostics Industry Expected To Reach By 2029, Starting From 2025 Levels?
The point of care hematology diagnostics market has experienced substantial growth in recent years. It is projected to increase from $2.66 billion in 2024 to $2.90 billion in 2025, achieving a compound annual growth rate (CAGR) of 9.1%. This historical expansion can be attributed to several factors including the rising prevalence of hematological disorders, the increasing adoption of decentralized healthcare settings, a growing focus on early disease detection, escalating healthcare expenditures in emerging markets, and the expanding use of portable diagnostic devices.
The point of care hematology diagnostics market size is anticipated to undergo substantial growth in the upcoming years. This market is projected to expand to $4.05 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 8.7%. This expansion during the forecast period is primarily fueled by the increasing embrace of personalized medicine, a rising need for immediate clinical decisions, the expanding requirement for home healthcare diagnostics, the growing occurrence of blood-related disorders, and heightened awareness regarding preventive healthcare. Significant developments expected in this period include advanced connectivity features in hematology analyzers, novel methods in sample preparation, the integration of artificial intelligence into diagnostic instruments, innovations in single-cell analysis, the adoption of cloud-based data platforms, and progress in lab-on-a-chip solutions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27388&type=smp
What Are The Drivers Pushing New Developments In The Point Of Care Hematology Diagnostics Market?
The anticipated expansion of the point-of-care hematology diagnostics market is driven by the growing occurrence of blood disorders. These disorders are conditions impacting blood components like red blood cells, white blood cells, platelets, or plasma. The heightened incidence of blood disorders largely stems from the increasing prevalence of chronic illnesses, which directly affect blood health and necessitate continuous monitoring. Point-of-care hematology diagnostics facilitate prompt detection and oversight of blood disorders by delivering fast, precise results at or close to the patient’s location, thereby allowing for quicker clinical judgments and enhanced disease management. For example, data from April 2024 by the Perth Blood Institute, an Australia-based non-profit, indicated that individuals diagnosed with hemophilia – a genetic condition causing prolonged bleeding due to insufficient clotting factors – reached 257,146 in 2022, an increase from 233,577 in 2021. Consequently, the growing occurrence of blood disorders is fueling the expansion of the point-of-care hematology diagnostics market.
What Are The Primary Types Of Segments Analyzed In The Point Of Care Hematology Diagnostics Market?
The point of care hematology diagnostics market covered in this report is segmented
1) By Type: Complete Blood Count, Coagulation Testing, Hemoglobin Testing, Anemia Diagnosis, Other Types
2) By Product: Consumables, Systems
3) By Mode Of Prescription: Prescription Based Product, Over-The-Counter Based Product
4) By End User: Diagnostic Centers, Hospitals, Blood Banks, Transfusion Centers, Other End Users
Subsegments:
1) By Complete Blood Count: White Blood Cell Count, Red Blood Cell Count, Platelet Count, Hematocrit, Hemoglobin Concentration, Mean Corpuscular Volume (MCV)
2) By Coagulation Testing: Prothrombin Time (PT), Activated Partial Thromboplastin Time (aPTT), International Normalized Ratio (INR), D-Dimer Test, Fibrinogen Level
3) By Hemoglobin Testing: Total Hemoglobin, Glycated Hemoglobin (HbA1c), Oxyhemoglobin, Carboxyhemoglobin, Methemoglobin
4) By Anemia Diagnosis: Iron Studies, Vitamin B12 Levels, Folate Levels, Reticulocyte Count, Ferritin Test, Transferrin Saturation
5) By Other Types: Blood Typing And Crossmatching, Erythrocyte Sedimentation Rate, Malaria Parasite Detection, Sickle Cell Screening, C-Reactive Protein Testing
What Long-Term Trends Will Shape The Future Growth Of The Point Of Care Hematology Diagnostics Industry?
Leading companies within the point-of-care hematology diagnostics market are prioritizing the creation of technologically advanced solutions, such as cartridge-based AI-powered hematology analyzers, to provide swift, precise, and on-site blood analysis for enhanced patient outcomes. Cartridge-based AI-powered hematology analyzers function as compact diagnostic tools, employing single-use reagent cartridges and artificial intelligence algorithms to rapidly and accurately examine blood samples at the point of care. As an example, in September 2024, Zoetis Inc., a US-based veterinary health company, introduced Vetscan OptiCell, a cartridge-based, AI-powered hematology analyzer specifically designed for veterinary applications. This cutting-edge system delivers rapid, reference laboratory-quality complete blood count (CBC) results in minutes directly at the point of care, concurrently minimizing maintenance and hands-on operational time. It incorporates advanced AI-driven image analysis alongside viscoelastic focusing technology that precisely positions cells for clear visualization, allowing for accurate blood cell classification and automated identification of abnormalities, thus ensuring efficient and reliable veterinary diagnostics.
Who Are The Primary Competitors In The Global Point Of Care Hematology Diagnostics Market?
Major companies operating in the point of care hematology diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, HORIBA Ltd., Nova Biomedical Corp., S.D. Sight Diagnostics Ltd., EKF Diagnostics Holdings plc., Medsource Ozone Biomedicals Pvt. Ltd., BioSystems S.A., Chengdu Seamaty Technology Co. Ltd., Drucker Diagnostics LLC, Diamond Diagnostics Inc., DIAGON Kft., BioMedomics Inc., Norma Instruments Zrt., PixCell Medical Technologies Ltd.
Download The Full Report For Exclusive Market Findings:
Which Geographies Are Emerging As Strong Markets For The Point Of Care Hematology Diagnostics Industry?
North America was the largest region in the point of care hematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point of care hematology diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Point Of Care Hematology Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27388&type=smp
Browse Through More Reports Similar to the Global Point Of Care Hematology Diagnostics Market 2025, By The Business Research Company
Pre Engineered Buildings Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pre-engineered-buildings-global-market-report
Architectural And Structural Metals Global Market Report 2025
Architectural And Structural Metals Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model